Ophthalmic Business News

Luminopia closed an oversubscribed $16 million Series A financing round, which will be used to support the commercial rollout of the Luminopia software-based therapeutic for amblyopia later this year, according to a press release.

The FDA issued a complete response letter for the biologics license application for aflibercept 8 mg for the treatment of wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy, according to a press release.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, Yari L. Mitchell discusses the ways that the meeting is driving innovation in eye care through fostering connections.

Aldeyra Therapeutics will seek to make its investigational drug candidate ADX-2191 available to patients with primary vitreoretinal lymphoma under an FDA expanded access program, according to a press release.

Eyenuk received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system for autonomous detection of diabetic retinopathy, according to a press release.

Cigna Healthcare has updated its glaucoma surgical procedure policy to cover both ab interno canaloplasty and goniotomy to treat primary open-angle glaucoma, according to a press release from Sight Sciences.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, Yari L. Mitchell shares her takeaways from the meeting on innovators in ophthalmology.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, Bill Carpou, CEO of Octane, discusses highlights from the meeting, including Haystax, an AI-driven investment tool.

Invirsa closed $7.7 million in Series B financing earlier this year, according to a press release.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, Ehsan Sadri, MD, FACS, discusses a panel that looked at the companies serving as disruptive innovators in eye care.